Health In Tech, Inc. declined 3.67% intraday, with the broader healthcare sector facing challenges. The S&P 500 healthcare sector, which includes pharmaceutical companies, biotechs, health insurers, and medical equipment makers, has slumped 5% in 2025, lagging the broader market. This decline is partly driven by Trump administration policies, including actions on pharma tariffs and drug pricing, which have clouded the outlook for healthcare stocks.
Comments
No comments yet